SCHEMBL25863238

SCHEMBL25863238

CCC1(CC)CC(=O)c2cc(-c3cc(-c4cccc(OO)c4)no3)ccc2O1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CXCR1 P25024 2/20 0.40
▸ HPGD P15428 3/20 0.38
▸ ALDH1A1 P00352 2/20 0.38
▸ MMP13 P45452 1/20 0.37
▸ PPARG P37231 2/20 0.37
▸ PPARA Q07869 2/20 0.37
▸ TP53 P04637 3/20 0.37
▸ SMN1; SMN2 Q16637 3/20 0.37
▸ MAOB P27338 1/20 0.36
▸ HSD17B1 P14061 1/20 0.36
▸ HSD17B2 P37059 1/20 0.36
▸ CYP2C19 P33261 3/20 0.35
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ CYP3A4 P08684 2/20 0.35
▸ CYP2C9 P11712 2/20 0.35
▸ CYP1A2 P05177 2/20 0.35
▸ CYP2D6 P10635 1/20 0.35
▸ ABCB1 P08183 1/20 0.35
▸ ABCC1 P33527 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23558238 0.93 ALDH1A1 (0.45) CXCR1HPGDALDH1A1TP53SMN1; SMN2
SCHEMBL25856900 0.87 MAOB (0.43) PPARGPPARATP53MAOBHSD17B1
SCHEMBL23558461 0.87 NPC1 (0.45) CXCR1HPGDMMP13TP53SMN1; SMN2
SCHEMBL25856895 0.82 RAB9A (0.42) CXCR1HPGDALDH1A1TP53SMN1; SMN2
SCHEMBL25856856 0.81 NPC1 (0.43) CXCR1HPGDMMP13TP53SMN1; SMN2
SCHEMBL25856949 0.81 CNR1 (0.41) CXCR1ALDH1A1MMP13SMN1; SMN2NPC1
SCHEMBL23558395 0.80 ABCB1 (0.38) HSD17B1HSD17B2NPC1RAB9AABCB1
SCHEMBL23558433 0.80 HSD17B1 (0.51) HPGDALDH1A1TP53SMN1; SMN2HSD17B1
SCHEMBL25863749 0.79 ABCB1 (0.35) ABCB1ABCC1CNR1CNR2S1PR1
SCHEMBL23558404 0.78 ABCB1 (0.51) HPGDALDH1A1MMP13NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME TREVENA, INC. 2023-07-27 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230234946-A1 COMPOUNDS FOR MODULATING S1P1 ACTIVITY AND METHODS OF USING THE SAME S1PR1, S1PR2, S1PR3 CXCR1 79/4885HPGD 3374/4885ALDH1A1 2583/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback